Skip to content

Research and development of intelligent pathological diagnosis and therapeutic effect prediction system based on multimodal information fusion of common tumors and major infectious diseases

Research and development of intelligent pathological diagnosis and therapeutic effect prediction system based on multimodal information fusion of common tumors and major infectious diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047860
Enrollment
Unknown
Registered
2021-06-27
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer, pulmonary tuberculosis, and COIVD-19

Interventions

Participants with the clinical diagnosis of lung cancer group:NA
Participants with the clinical diagnosis of pulmonary tuberculosis group:NA
Participants with the clinical diagnosis of COIVD-19 group:NA

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients with clinical diagnosis of lung cancer, pulmonary tuberculosis and COIVD-19; 2. Participants who have signed informed consent; 3. The age of the research object is > 18 years old and < 90 years old; 4. Participants have detailed electronic medical records, imaging records, pathological records, multi-omics information and other important clinical diagnostic information; 5. Healthy subjects without clinical diagnosis of lung cancer, tuberculosis and COIVD-19.

Exclusion criteria

Exclusion criteria: 1. Subjects with missing original clinicopathological data; 2. Subjects lost to follow-up; 3. Participants with too poor medical image quality were unable to accurately segment and label ROIs.

Design outcomes

Primary

MeasureTime frame
Patients' general information: epidemiological indicators such as age, gender, address, telephone, past medical history, and BMI;Metabolomics;Genomics;Transcriptomics;Proteomics;Laboratory inspection;Radiomics;Etiological examination;The remaining observation indicators aie supplemented according to clinical needs.;

Countries

China

Contacts

Public ContactJin Yang

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

whuhjy@sina.com+86 13554361146

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026